Metabolic Health Summer Series: The Future of Metabolic Health: Weight-Loss Medication Benefits for Positive Impact on Your Population and Your Bottom Line
Obesity and other metabolic conditions are contributing to a significant increase in health issues worldwide. Many employers are now experiencing a sharp increase in utilization of anti-obesity medications, including GLP–1 drugs. Join the Brown & Brown Population Health & Well-Being team and our distinguished guest speakers in a three-part webinar series on strategies to help address metabolic health.
The Future of Metabolic Health: Weight-Loss Medication Benefits for Positive Impact on Your Population and Your Bottom Line
Wednesday, August 16, 2023 1:00 – 2:00 PM CDT
Join us to discuss how GLP-1 and antiobesity drugs are changing the healthcare landscape. The team will take a more holistic look at the therapeutic impacts and the potential outcomes employers should consider. We will also cover plan design considerations that will help members find the proper care and treatment and achieve outcomes for the long term while also helping to protect the financial interest of the organization.
Speakers
- Tim Church, M.D., Ph.D., M.P.H., Chief Medical Officer, Wondr Health
- Louise Short, M.D., M.Sc. FACOEM, National Clinical Leader, Brown & Brown
REGISTER HERE
Sign up for the next webinar in our summer series:
- Beyond the Drugs: HumanCentered Strategy that Supports the Metabolic Health of Your Employees
Wednesday, September 13, 2023 1:00 – 2:00 PM CDT
Watch the first webinar from the series:
DISCLAIMER: Brown & Brown, Inc. and all its affiliates, do not provide legal, regulatory or tax guidance, or advice. If legal advice counsel or representation is needed, the services of a legal professional should be sought. The information in this document is intended to provide a general overview of the topics and services contained herein. Brown & Brown, Inc. and all its affiliates, make no representation or warranty as to the accuracy or completeness of the document and undertakes no obligation to update or revise the document based upon new information or future changes.
